CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Eli Lilly & Co - LLY CFD

337.93
2.28%
2.49
Low: 329.73
High: 341.12
Market Trading Hours* (UTC) Opens on Monday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 2.49
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.030779 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.030779%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.013666 %
Charges from borrowed part ($-0.55)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.013666%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Eli Lilly and Co ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 330.39
Open* 329.73
1-Year Change* 31.38%
Day's Range* 329.73 - 341.12
52 wk Range 231.87-384.44
Average Volume (10 days) 3.96M
Average Volume (3 months) 58.70M
Market Cap 314.22B
P/E Ratio 47.91
Shares Outstanding 950.18M
Revenue 28.54B
EPS 6.90
Dividend (Yield %) 1.3668
Beta 0.33
Next Earnings Date Apr 27, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 3, 2023 337.93 5.58 1.68% 332.35 342.09 328.30
Feb 2, 2023 330.39 -2.41 -0.72% 332.80 334.80 316.14
Feb 1, 2023 342.15 1.23 0.36% 340.92 345.40 336.80
Jan 31, 2023 343.91 5.17 1.53% 338.74 344.11 338.74
Jan 30, 2023 340.18 -1.86 -0.54% 342.04 347.28 339.15
Jan 27, 2023 341.77 -2.99 -0.87% 344.76 347.70 341.32
Jan 26, 2023 347.65 -2.14 -0.61% 349.79 351.79 346.30
Jan 25, 2023 349.26 7.35 2.15% 341.91 349.50 341.91
Jan 24, 2023 345.92 -16.82 -4.64% 362.74 364.89 339.80
Jan 23, 2023 341.82 -2.04 -0.59% 343.86 345.86 339.80
Jan 20, 2023 345.80 1.01 0.29% 344.79 348.73 341.12
Jan 19, 2023 350.82 1.39 0.40% 349.43 355.30 349.43
Jan 18, 2023 351.45 -4.05 -1.14% 355.50 358.73 351.25
Jan 17, 2023 357.38 -1.09 -0.30% 358.47 361.50 356.17
Jan 13, 2023 361.23 6.08 1.71% 355.15 362.95 355.15
Jan 12, 2023 358.72 3.25 0.91% 355.47 360.15 351.69
Jan 11, 2023 359.86 7.67 2.18% 352.19 361.49 348.71
Jan 10, 2023 352.54 5.75 1.66% 346.79 352.96 342.22
Jan 9, 2023 349.45 -13.34 -3.68% 362.79 364.60 348.43
Jan 6, 2023 362.71 4.92 1.38% 357.79 366.20 356.41

Eli Lilly & Co Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 21222.1 19973.8 21493.3 22319.5 24539.8 28318.4
Revenue 21222.1 19973.8 21493.3 22319.5 24539.8 28318.4
Cost of Revenue, Total 5654.9 4447.7 4681.7 4721.2 5483.3 7312.8
Gross Profit 15567.2 15526.1 16811.6 17598.3 19056.5 21005.6
Total Operating Expense 17763.3 17970.5 17958.8 17287.9 18481.8 22366.5
Selling/General/Admin. Expenses, Total 6452 5982.4 5975.1 6213.8 6121.2 6431.6
Research & Development 5243.9 5096.2 5051.2 5595 6085.7 7025.9
Unusual Expense (Income) 412.5 2444.2 2250.8 757.9 791.6 1596.2
Operating Income 3458.8 2003.3 3534.5 5031.6 6058 5951.9
Interest Income (Expense), Net Non-Operating -76.5 -58.6 -83.2 -320.2 -326.6 -137.5
Other, Net -8.3 360.1 228.8 554.5 1498.5 341.1
Net Income Before Taxes 3374 2304.8 3680.1 5265.9 7229.9 6155.5
Net Income After Taxes 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Net Income Before Extra. Items 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Net Income 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Income Available to Common Excl. Extra. Items 2737.6 4493.6 3325.9 4637.9 6193.7 5581.7
Income Available to Common Incl. Extra. Items 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Diluted Net Income 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Diluted Weighted Average Shares 1061.82 1052.02 1033.67 935.684 912.505 911.681
Diluted EPS Excluding Extraordinary Items 2.5782 4.27139 3.21757 4.95669 6.78758 6.12243
Dividends per Share - Common Stock Primary Issue 2.04 2.08 2.25 2.58 2.96 3.4
Diluted Normalized EPS 2.89874 6.15171 5.37021 5.70063 7.63447 7.79951
Total Extraordinary Items -4697.7 -93.9 3680.5 0 0
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 6805.6 6740.1 6772.8 7999.9 7810
Revenue 6805.6 6740.1 6772.8 7999.9 7810
Cost of Revenue, Total 1878.6 1953.2 1430.8 2050.2 2072.1
Gross Profit 4927 4786.9 5342 5949.7 5737.9
Total Operating Expense 5650.3 5336.7 5296.8 6082.7 5405.7
Selling/General/Admin. Expenses, Total 1576 1685.7 1577.9 1592 1557.9
Research & Development 1684.8 1672.8 1708.9 1959.4 1610.1
Unusual Expense (Income) 510.9 25 579.2 481.1 165.6
Operating Income 1155.3 1403.4 1476 1917.2 2404.3
Interest Income (Expense), Net Non-Operating 219.2 133.9 -323.4 -167.2 -503.3
Other, Net 101.9 56.6 92.7 89.9 152.6
Net Income Before Taxes 1476.4 1593.9 1245.3 1839.9 2053.6
Net Income After Taxes 1355.3 1390.2 1110.1 1726.1 1902.9
Net Income Before Extra. Items 1355.3 1390.2 1110.1 1726.1 1902.9
Net Income 1355.3 1390.2 1110.1 1726.1 1902.9
Income Available to Common Excl. Extra. Items 1355.3 1390.2 1110.1 1726.1 1902.9
Income Available to Common Incl. Extra. Items 1355.3 1390.2 1110.1 1726.1 1902.9
Diluted Net Income 1355.3 1390.2 1110.1 1726.1 1902.9
Diluted Weighted Average Shares 912.4 910.4 910.8 911.624 906.4
Diluted EPS Excluding Extraordinary Items 1.48542 1.52702 1.21882 1.89343 2.0994
Dividends per Share - Common Stock Primary Issue 0.85 0.85 0.85 0.85 0.98
Diluted Normalized EPS 2.02635 1.55448 1.80644 2.41408 2.28211
Total Extraordinary Items 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 15101.4 19202.1 20549.6 13709.6 17462.1 18452.4
Cash and Short Term Investments 6038.6 8034.1 7408.9 2438.5 3681.3 3908.6
Cash & Equivalents 4582.1 6536.2 7320.7 2337.5 3657.1 3818.5
Short Term Investments 1456.5 1497.9 88.2 101 24.2 90.1
Total Receivables, Net 4766.3 5262.2 5776.8 5541.5 6929 8127.2
Accounts Receivable - Trade, Net 4029.4 4546.3 5776.8 4547.3 5875.3 6672.8
Total Inventory 3561.9 4458.3 3098.1 3190.7 3980.3 3886
Prepaid Expenses 734.6 1447.5 2036.7 2538.9 2871.5 2530.6
Total Assets 38805.9 44981 43908.4 39286.1 46633.1 48806
Property/Plant/Equipment, Total - Net 8252.6 8826.5 7996.1 8405 8681.9 8985.1
Property/Plant/Equipment, Total - Gross 16777.6 18091.1 16663 17566.6 18252.6 18961.8
Accumulated Depreciation, Total -8525 -9264.6 -8666.9 -9161.6 -9570.7 -9976.7
Goodwill, Net 3972.7 4370.1 1366.6 3679.4 3766.5 3892
Intangibles, Net 4357.9 4029.2 1068 6618 7450 7691.9
Long Term Investments 5207.5 5678.8 2005.4 1962.4 2966.8 3212.6
Other Long Term Assets, Total 1913.8 2874.3 10922.7 4911.7 6305.8 6572
Total Current Liabilities 10986.6 14535.9 11888.1 11775.2 12481.6 15052.7
Accounts Payable 1349.3 1410.7 1207.1 1405.3 1606.7 1670.6
Accrued Expenses 896.9 997.9 955.6 915.5 997.2 958.1
Notes Payable/Short Term Debt 1299.3 2696.8 498.9 1494.2 0 0
Current Port. of LT Debt/Capital Leases 638.1 1009.8 603.3 5.1 8.7 1538.3
Other Current Liabilities, Total 6803 8420.7 8623.2 7955.1 9869 10885.7
Total Liabilities 24798.2 33388.8 34079.7 36679.2 40991.5 39826.8
Total Long Term Debt 8367.8 9940.5 9196.4 13817.9 16586.6 15346.4
Long Term Debt 8358.8 9931.8 9196.4 13817.9 16586.6 15346.4
Capital Lease Obligations 9 8.7
Minority Interest 72.8 75.7 1080.4 92.2 183.6 175.6
Other Liabilities, Total 5371 8836.7 10602.1 8806.4 9639.8 7518.4
Total Equity 14007.7 11592.2 9828.7 2606.9 5641.6 8979.2
Common Stock 688.5 687.9 661 598.8 598.2 596.3
Additional Paid-In Capital 5640.6 5817.8 6583.6 6685.3 6778.5 6833.4
Retained Earnings (Accumulated Deficit) 16046.3 13894.1 11395.9 4920.4 7830.2 8958.5
Treasury Stock - Common -80.5 -75.8 -69.4 -60.8 -55.7 -52.7
Unrealized Gain (Loss) 224 113.5 4.9 14.8 3.7
Other Equity, Total -8511.2 -8845.3 -8742.4 -9541.7 -9524.4 -7360
Total Liabilities & Shareholders’ Equity 38805.9 44981 43908.4 39286.1 46633.1 48806
Total Common Shares Outstanding 1100.88 1100.01 1057.64 957.526 956.59 953.653
Other Current Assets, Total 2229.1 0
Deferred Income Tax 1312.7 2187.5 2099.9 1733.7
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 16604.5 17295.5 17808.3 18452.4 16964.7
Cash and Short Term Investments 3051.4 3271.2 3825.3 3908.6 2568.3
Cash & Equivalents 3002.4 3220 3788.2 3818.5 2459.2
Short Term Investments 49 51.2 37.1 90.1 109.1
Total Receivables, Net 6658.6 6902.8 7025 8127.2 7805.7
Accounts Receivable - Trade, Net 5592.8 5829.4 5914.3 6672.8 6322.5
Total Inventory 3660.8 3824.9 3907.4 3886 3893
Prepaid Expenses 3233.7 3296.6 3050.6 2530.6 2697.7
Total Assets 46838.3 47809 48187 48806 46919.3
Property/Plant/Equipment, Total - Net 8630.1 8855.5 8920.4 8985.1 9102.7
Property/Plant/Equipment, Total - Gross 18273.5 18697.7 18883.2 18961.8 19241
Accumulated Depreciation, Total -9643.4 -9842.2 -9962.8 -9976.7 -10138.3
Goodwill, Net 3877.4 3884.2 3884.1 3892 3892
Intangibles, Net 8087.8 7985.4 7887.7 7691.9 7482.4
Long Term Investments 3232.4 3474.9 3350.5 3212.6 2727.3
Other Long Term Assets, Total 6406.1 6313.5 6336 6572 6750.2
Total Current Liabilities 11714.2 15093.2 13682 15052.7 13386
Accounts Payable 1639.6 1597.8 1566.8 1670.6 1433.3
Accrued Expenses 649.9 755.5 836.6 958.1 693.1
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 4.9 1778.5 1563 1538.3 1355.9
Other Current Liabilities, Total 9419.8 10961.4 9715.6 10885.7 9903.7
Total Liabilities 39939.6 41364.6 40430 39826.8 37588.5
Total Long Term Debt 16199.6 14736.6 15522.4 15346.4 15152.9
Long Term Debt 16199.6 14736.6 15522.4 15346.4 15152.9
Deferred Income Tax 2200.6 1857.3 1632.5 1733.7 1286.1
Minority Interest 200.6 219.1 197.1 175.6 131.2
Other Liabilities, Total 9624.6 9458.4 9396 7518.4 7632.3
Total Equity 6898.7 6444.4 7757 8979.2 9330.8
Common Stock 599.7 598.1 598.2 596.3 594.1
Additional Paid-In Capital 6579.2 6669.2 6758 6833.4 6656.3
Retained Earnings (Accumulated Deficit) 9181.3 8530.1 9639.4 8958.5 9369.4
Treasury Stock - Common -52.7 -52.7 -52.7 -52.7 -50.5
Unrealized Gain (Loss) 4.5 9.1 6.8 3.7 -18.1
Other Equity, Total -9413.3 -9309.4 -9192.7 -7360 -7220.4
Total Liabilities & Shareholders’ Equity 46838.3 47809 48187 48806 46919.3
Total Common Shares Outstanding 959.019 956.575 956.589 953.653 950.155
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line 2737.6 -204.1 3232 8318.4 6193.7 5581.7
Cash From Operating Activities 4851 5615.6 5524.5 4836.6 6499.6 7260.7
Cash From Operating Activities 1496.6 1567.3 1609 1232.6 1323.9 1547.6
Deferred Taxes 439.5 -787.9 326.8 62.4 -134.5 -802.3
Non-Cash Items 661.4 1835.4 2735.4 -3089.6 -136.1 1956.3
Cash Taxes Paid 700.6 246.5 1101.5 1180.5 954.6 1598.8
Cash Interest Paid 146.4 192.7 223.8 305.5 345.8 338
Changes in Working Capital -484.1 3204.9 -2378.7 -1687.2 -747.4 -1022.6
Cash From Investing Activities -3139.1 -3783.6 1906 -8082.9 -2258.9 -2762.3
Capital Expenditures -1092 -2163.6 -3018.2 -1353.5 -2029.1 -1873.2
Other Investing Cash Flow Items, Total -2047.1 -1620 4924.2 -6729.4 -229.8 -889.1
Cash From Financing Activities -559.8 142.6 -5904.9 -2324.5 -3137.1 -4131.3
Financing Cash Flow Items -300.8 -364.4 -372.8 -200.1 -241.6 -295.9
Total Cash Dividends Paid -2158.5 -2192.1 -2311.8 -2409.8 -2687.1 -3086.8
Issuance (Retirement) of Stock, Net -600.1 -299.8 -2491 -4400 -500 -1250
Issuance (Retirement) of Debt, Net 2499.6 2998.9 -729.3 4685.4 291.6 501.4
Foreign Exchange Effects -236.4 -20.5 -63.6 -89.9 216 -205.7
Net Change in Cash 915.7 1954.1 1462 -5660.7 1319.6 161.4
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 1355.3 2745.5 3855.6 5581.7 1902.9
Cash From Operating Activities 1697.4 3472.9 5104.2 7260.7 2499.2
Cash From Operating Activities 350.3 719.6 1101.9 1547.6 435.7
Deferred Taxes -119.1 -413.8 -709.8 -802.3 -506.6
Non-Cash Items 213.7 303.2 1404.6 1956.3 712.7
Changes in Working Capital -102.8 118.4 -548.1 -1022.6 -45.5
Cash From Investing Activities -1283.5 -1766.8 -2383.3 -2762.3 -1013.8
Capital Expenditures -492.1 -1023.4 -1479 -1873.2 -857.2
Other Investing Cash Flow Items, Total -791.4 -743.4 -904.3 -889.1 -156.6
Cash From Financing Activities -1058.4 -2141.6 -2604.8 -4131.3 -2878.3
Financing Cash Flow Items -279.9 -294.8 -295.3 -295.9 -282.4
Total Cash Dividends Paid -774.8 -1543.1 -2313.5 -3086.8 -885.5
Issuance (Retirement) of Stock, Net 0 -500 -500 -1250 -1500
Issuance (Retirement) of Debt, Net -3.7 196.3 504 501.4 -210.4
Foreign Exchange Effects -10.2 -1.6 15 -205.7 33.6
Net Change in Cash -654.7 -437.1 131.1 161.4 -1359.3
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Lilly Endowment, Inc. Investment Advisor 10.8347 102948810 -210000 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 7.6008 72221213 994066 2022-09-30 LOW
PNC Wealth Management Investment Advisor 5.4451 51738161 -44061 2022-09-30 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.2364 40253792 58949 2022-09-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 3.5343 33582472 168444 2022-09-30 LOW
Fidelity Management & Research Company LLC Investment Advisor 3.3604 31929656 631015 2022-09-30 LOW
Capital World Investors Investment Advisor 3.0547 29024874 282228 2022-09-30 LOW
PRIMECAP Management Company Investment Advisor 2.9486 28017155 -421333 2022-09-30 LOW
T. Rowe Price Associates, Inc. Investment Advisor 2.5054 23805927 3379269 2022-09-30 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.2989 21843288 -1593968 2022-09-30 LOW
State Farm Insurance Companies Insurance Company 1.8324 17410725 0 2022-09-30 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.6935 16091249 373938 2022-09-30 LOW
Jennison Associates LLC Investment Advisor/Hedge Fund 1.0592 10064742 -293324 2022-09-30 LOW
JP Morgan Asset Management Investment Advisor 0.866 8228610 173535 2022-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.8435 8014500 -246196 2021-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7439 7068030 -132558 2022-09-30 LOW
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.6244 5933104 -307204 2022-09-30 LOW
Capital International Investors Investment Advisor 0.5893 5599174 637189 2022-09-30 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.5885 5591703 -216451 2022-09-30 LOW
BofA Global Research (US) Research Firm 0.5868 5576096 -144521 2022-09-30 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
+485000+

Traders

65000+

Active clients monthly

$48000000+

Monthly investing volume

$28000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Eli Lilly Company profile

Eli Lilly and Company is engaged in the drug manufacturing business. The company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products.  Explore the Eli Lilly stock at Capital.com. Monitor Lilly shares in real time. With our website you can stay updated on Lilly share price.  

Industry: Pharmaceuticals (NEC)

Lilly Corporate Ctr
Drop Code 1094
INDIANAPOLIS
INDIANA 46285-0001
US

Income Statement

  • Annual
  • Quarterly

People also watch

Oil - Crude

73.41 Price
-3.570% 1D Chg, %
Long position overnight fee -0.0223%
Short position overnight fee 0.0065%
Overnight fee time 22:00 (UTC)
Spread 0.03

BTC/USD

23,434.70 Price
+0.090% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

Natural Gas

2.41 Price
-2.390% 1D Chg, %
Long position overnight fee -0.1138%
Short position overnight fee 0.0796%
Overnight fee time 22:00 (UTC)
Spread 0.005

US100

12,566.80 Price
-0.450% 1D Chg, %
Long position overnight fee -0.0183%
Short position overnight fee 0.0071%
Overnight fee time 22:00 (UTC)
Spread 3.0

Still looking for a broker you can trust?

Join the 480.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading